The electronic version of this document is currently unavailable

Active substance: lidocaine hydrochloride / phenylephrine ...

Sep 2, 2016 - Fydrane 0.2 mg/ml + 3.1 mg/ml + 10 mg/ml solution for injection. DK/H/2439/001. PA 1107/012/001. LABORATOIRES THEA. IE. FYDRANE, 0,2 ...

42KB Sizes 0 Downloads 227 Views

Recommend Documents

Lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide ...
Sep 1, 2017 - Send a question via our website www.ema.europa.eu/contact. © European Medicines Agency ... Product Name (in authorisation country). MRP/ ...

lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide ...
Mar 8, 2018 - Member State where product is authorised. Mydane 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml injeksjonsvæske, oppløsning. DK/H/2439/001. 14/10062.

Active substance: chloroquine Regulatory outcome: variation
Mar 31, 2016 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom ... Procedure Management and Committees Support. List of ...

Active substance: valaciclovir Regulatory outcome: maintenance
Sep 2, 2016 - SIGMA-TAU INDUSTRIE. FARMACEUTICHE RIUNITE. S.P.A.. IT. Valaciclovir ”Orion”. UK/H/2940/01/DC. 44083. ORION OYJ. DK. Valaciclovir ...

Active substance - European Medicines Agency - Europa EU
May 13, 2016 - Procedure Management and Committees Support. List of nationally authorised medicinal ... MRP UK/H/0464/002. IS/1/07/020/01. Santen Oy.

Active substance: testosterone undecanoate; Regulatory Outcome ...
Oct 29, 2016 - Taking into account the PRAC Assessment Report on the PSUR(s) for ... 3. Annex II. Amendments to the product information of the nationally ...

Active substance: Cefoperazone Regulatory outcome: variation
Oct 29, 2016 - Taking into account the PRAC Assessment Report on the PSUR(s) for ... 3. Annex II. Amendments to the product information of the nationally ...

Active substance: Cefoperazone Regulatory outcome: variation
Oct 29, 2016 - should be discontinued if there is persistent bleeding and no alternative explanations are identified. Package Leaflet. 2. Warnings and precautions. Cefoperazone - active substance of – may inhibit blood clotting. Serious bleedings,

Active substance: Azithromycin: CMDh scientific conclusions and ...
Mar 10, 2018 - Scientific conclusions. Taking into account the PRAC Assessment Report on the PSUR(s) for azithromycin (systemic use formulations), the scientific conclusions are as follows: In view of the increasing understanding on drug-drug interac

Active substance: bisoprolol Regulatory outcome: maintenance
May 13, 2016 - Concor COR 1,25 mg filmom obložene tablete. SE/H/0184/001. HR-H-350108325-04. MERCK D.O.O. HR. Full application. (Article 8(3) of.

Active substance: valaciclovir Regulatory outcome - European ...
Sep 2, 2016 - THE WELLCOME FOUNDATION. LTD. GR. Valtrex 250 mg comprimidos revestidos por película. SE/H/1041/001. 2966083. LABORATORIOS WELLCOME DE. PORTUGAL LIMITADA. PT. Valtrex 250 mg comprimidos revestidos por película. SE/H/1041/001. 3131786.

Active substance: influenza vaccine (surface antigen, inactivated ...
Apr 14, 2016 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of ... Procedure Management and Committees Support.

Active substance: hydromorphone Regulatory outcome: variation
Oct 29, 2016 - Amendments to be included in the relevant sections of the Product Information (new text underlined and in bold, deleted text strike through). Summary of Product Characteristics. •. Section 4.6. Prolonged use of hydromorphone during p

Active substance - European Medicines Agency - Europa EU
Sep 29, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in ... Erdomed 300 mg - Kapseln not available.

Active substance: mefloquine: CMDh scientific conclusions and ...
Dec 23, 2017 - 2. Scientific conclusions. Taking into account the PRAC Assessment Report on the PSUR(s) for mefloquine, the scientific conclusions are as follows: ... Amendments to be included in the relevant sections of the Product Information (new

Active substance: lisinopril - Regulatory ... - European Medicines Agency
May 13, 2016 - EMA/388981/2016. Procedure Management and Committees Support ... Lisinopril Brown & Burk. Uk. PL 25298/0118 $ PL 25298/0119 $.

Active substance: rabeprazole - Regulatory outcome: maintenance
Jun 9, 2016 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom ... Procedure Management and Committees Support. List of ...

Active substance: ketamine Regulatory outcome: maintenance
Sep 2, 2016 - Send a question via our website www.ema.europa.eu/contact ... Ketalar 50 mg/ml injeksjonsvæske, oppløsning not available. 5724. PFIZER AS.

Active substance: artemether / lumefantrin (dispersible tablet ...
Jun 9, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ... not available. PL 00101/0957.

Active substance: magnesium hydroxide: CMDh scientific conclusions ...
Sep 2, 2017 - Taking into account the PRAC Assessment Report on the PSUR(s) for magnesium hydroxide, the scientific conclusions are as follows:.

Active substance: rupatadine Regulatory outcome - European ...
Feb 11, 2016 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom ... Procedure Management and Committees Support. List of ...

Active substance: influenza vaccine (surface antigen, inactivated ...
Apr 14, 2016 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525. Send a question via our website www.ema.europa.eu/contact. © European ...

Active substance: Captopril-hydrochlorothiazide Regulatory outcome ...
Jan 28, 2017 - The primary analysis examined sudden death within seven days of an outpatient prescription for one of ... Package Leaflet. •. Section 2.

Active substance: hydromorphone Regulatory outcome: variation
Oct 29, 2016 - Taking into account the PRAC Assessment Report on the PSUR(s) for ... 3. Annex II. Amendments to the product information of the nationally ...